A new study published in the Journal of Neuroimmunology1 indicates that disease severity of muscle-specific kinase (MuSK) myasthenia gravis (MG) could be linked to MuSK antibody levels. The ...

An fresh look at trial results that propelled the only FDA approval of a chimeric antigen receptor (CAR) T-cell therapy for mantle cell lymphoma (MCL) shows prior treatment with ibrutinib, a ...

Adults living with idiopathic hypersomnia and narcolepsy type 1 often report cognitive difficulties, including problems with memory, attention, and mental fatigue. However, new research published in ...

The Gulliver-Gestalt-Psoriasis Area Severity Estimate (G2-PASE) was developed to address a longstanding challenge in ...

In this interview with the study’s lead author, Sarah M. Lima, PhD, MPH, an epidemiologist and postdoctoral fellow in cancer populations at the Georgetown Lombardi Comprehensive Cancer Center, she ...

Amin Mirhadi, MD, is an assistant professor at Cedars-Sinai Medical Center in Los Angeles, California, where he is the ...

Importantly, several studies evaluated CBT-I as an adjunct to usual care for comorbid mental health conditions such as ...

A new study links telomere length genetics to IPF risk, showing how rare variants and polygenic scores may guide future screening and precision care.

The 2026 International Stroke Conference (ISC), held February 4-6 in New Orleans, Louisiana, delivered potentially ...

Study finds breast cancer survival gaps tied to historical redlining narrowed over time, though newer therapies may be widening disparities again.

David Zhang, MD, is a pulmonary disease medicine specialist at Columbia University Irving Medical Center. A new study links telomere length genetics to IPF risk, showing how rare variants and ...

“Decision-making is a critical component of health care delivery, but the number of therapies available can be overwhelming to patients, preventing them from making fully informed care decisions,” the ...